Results 11 to 20 of about 254,670 (209)

Spirometry and Obstructive Lung Disease in Manitoba [PDF]

open access: yesCanadian Respiratory Journal, 2001
BACKGROUND: Spirometry, the measurement of forced expiratory volume in 1 s and forced vital capacity, is recommended in the diagnosis and management of the obstructive lung diseases asthma and chronic obstructive pulmonary disease (COPD). The present report describes spirometry use in Manitoba and tests the hypothesis that regional spirometry use ...
Anthonisen, NR   +3 more
openaire   +5 more sources

Descriptors of dyspnea in obstructive lung diseases [PDF]

open access: yesMultidisciplinary Respiratory Medicine, 2010
In obstructive lung diseases such as asthma and COPD dyspnea is a common respiratory symptom with different characteristics given the different pathogenic mechanisms: in COPD initially it can occur during exertion but then it increases progressively along with the airflow obstruction, whereas in asthma it occurs episodically and is caused by transient ...
Antoniu Sabina A
openaire   +5 more sources

Association of ABO Blood group phenotypes with FEV1/FVC values among students of Aziz Fatima Medical and Dental College [PDF]

open access: yesJournal of Rawalpindi Medical College
Objective: To find the frequency of obstructive and restrictive lung disease in various blood groups in young students of Aziz Fatimah Medical and dental college.
Altaf, Benash   +5 more
core   +4 more sources

Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study

open access: yesFrontiers in Pharmacology, 2023
Introduction: The availability of highly effective triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator combination therapy with elexacaftor–tezacaftor–ivacaftor (ETI) has improved pulmonary outcomes and quality of life of people ...
Sabine Dettmer   +16 more
doaj   +1 more source

Ciliary Ultrastructure Assessed by Transmission Electron Microscopy in Adults with Bronchiectasis and Suspected Primary Ciliary Dyskinesia but Inconclusive Genotype

open access: yesCells, 2023
Whole-exome sequencing has expedited the diagnostic work-up of primary ciliary dyskinesia (PCD), when used in addition to clinical phenotype and nasal nitric oxide. However, it reveals variants of uncertain significance (VUS) in established PCD genes or (
Ben O. Staar   +9 more
doaj   +1 more source

Interleukin‐17A and interleukin‐22 production by conventional and non‐conventional lymphocytes in three different end‐stage lung diseases

open access: yesClinical & Translational Immunology, 2022
Objectives The contribution of adaptive vs. innate lymphocytes to IL‐17A and IL‐22 secretion at the end stage of chronic lung diseases remains largely unexplored. In order to uncover tissue‐ and disease‐specific secretion patterns, we compared production
Melanie Albrecht   +14 more
doaj   +1 more source

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients

open access: yesBiomolecules, 2022
Alpha-1-Antitrypsin (AAT) is a protein of the SERPINA1 gene. A single amino acid mutation (Lys342Glu) results in an expression of misfolded Z-AAT protein, which has a high propensity to intra- and extra-cellular polymerization.
Annelot D. Sark   +6 more
doaj   +1 more source

Prevalence of postoperative pulmonary complications in recipients of liver transplantation with abnormal preoperative spirometry. [PDF]

open access: yesJ Int Med Res
Objective To determine the incidence of postoperative pulmonary complications in liver transplantation recipients with abnormal preoperative spirometry.
Khan S, Zainab A, Amin S, Iqbal R.
europepmc   +2 more sources

Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity

open access: yesFrontiers in Pharmacology, 2023
Introduction: Triple-combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy with elexacaftor/tezacaftor/ivacaftor (ETI) was introduced in August 2020 in Germany for people with CF (pwCF) ≥12 years (yrs.) of age and in ...
Katharina Schütz   +26 more
doaj   +1 more source

Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs

open access: yeseLife, 2021
Expression levels of CX3CR1 (C-X3-C motif chemokine receptor 1) on immune cells have significant importance in maintaining tissue homeostasis under physiological and pathological conditions.
Srinu Tumpara   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy